ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,467,064, issued on Nov. 11, was assigned to Allen Institute (Seattle) and Seattle Children's Hospital (Seattle).

"Artificial expression constructs for selectively modulating gene expression in interneurons" was invented by Jonathan Ting (Lake Forest Park, Wash.), Boaz P. Levi (Seattle), John K. Mich (Seattle), Edward Sebastian Lein (Mercer Island, Wash.) and Franck Kalume (Bothell, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Artificial expression constructs for selectively modulating gene expression in selected central nervous system cell types are described. The artificial expression constructs can be used to selectively express synthetic gene...